Waverly Advisors, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1568787 BIRMINGHAM, AL

Position in CRSP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$862,158

+$101,411 QoQ

Shares Held

18,124

+24.9% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 8.364599426175237.ToString("F0")% Shared 0.ToString("F0")% None 91.63540057382477.ToString("F0")%

Healthcare · as of Mar 31, 2026

Waverly Advisors, LLC holds $22,088,789 across 17 Biotechnology names. CRSP ranks #6 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,055	$10,294,979
2	REGN	Regeneron Pharmaceuticals, Inc.	5,895	$4,554,712
3	SYRE	Spyre Therapeutics, Inc.	25,966	$1,309,725
4	VKTX	Viking Therapeutics, Inc.	38,218	$1,243,613
5	EYPT	EyePoint, Inc.	77,914	$1,004,311
6	CRSP	CRISPR Therapeutics AG This page	18,124	$862,158
7	INCY	Incyte Corp	8,242	$775,737
8	EXEL	Exelixis, Inc.	12,665	$543,201

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$862,158	18,124	+24.9%	Shares	Sole	2026-05-15
2025-12-31	$760,747	14,507	+0.8%	Shares	Sole	2026-02-17
2025-09-30	$932,810	14,393	-6.5%	Shares	Sole	2025-11-14
2025-06-30	$748,569	15,390	+0.9%	Shares	Sole	2025-08-14
2025-03-31	$518,855	15,247	-1.6%	Shares	Sole	2025-05-15
2024-12-31	$609,883	15,495	-20.1%	Shares	Sole	2025-02-14
2024-09-30	$911,036	19,392	+10.9%	Shares	Sole	2024-11-14
2024-06-30	$944,364	17,485	+92.5%	Shares	Sole	2024-08-14
2024-03-31	$618,960	9,081	+110.8%	Shares	Sole	2024-05-15
2023-12-31	$269,618	4,307	-5.5%	Shares	Sole	2024-02-14
2023-06-30	$255,829	4,557	—	Shares	Sole	2023-08-15
No filing history on record for this holder in this stock.